Sign inGet started

Nicaise Claude

Insider CIK 1644162 · SAVA Director · CMMB Director · GANX Director · SRPT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GANX Gain Therapeutics, Inc. A Award deriv2026-07-152026-07-1725,000— $025,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2026-06-042026-06-0516,875— $048,407SEC↗
SRPT Sarepta Therapeutics, Inc. M Exercise deriv2026-01-292026-01-2910,500— $00SEC↗
SRPT Sarepta Therapeutics, Inc. M Exercise2026-01-292026-01-2910,500$13.71 $144.0K38,312SEC↗
SRPT Sarepta Therapeutics, Inc. F Tax w/h2026-01-292026-01-296,780$21.23 $143.9K31,532SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2025-06-242025-06-2515,000— $015,000SEC↗
SAVA CASSAVA SCIENCES INC A Award deriv2025-05-232025-05-2726,500— $026,500SEC↗
SRPT Sarepta Therapeutics, Inc. M Exercise deriv2025-03-122025-03-139,746— $00SEC↗
SRPT Sarepta Therapeutics, Inc. M Exercise2025-03-122025-03-139,746$25.18 $245.4K30,303SEC↗
SRPT Sarepta Therapeutics, Inc. S Sale2025-03-122025-03-132,491$99.64 $248.2K27,812SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2025-03-102025-03-114,792— $020,557SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2025-03-102025-03-112,383— $020,557SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2024-06-242024-06-2615,000— $015,000SEC↗
SAVA CASSAVA SCIENCES INC A Award deriv2024-05-092024-05-1310,000— $010,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2024-03-012024-03-053,679— $03,679SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2024-03-012024-03-051,846— $018,174SEC↗
SAVA CASSAVA SCIENCES INC A Award deriv2023-12-062023-12-0820,000— $020,000SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2023-06-232023-06-2610,500— $010,500SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2023-03-162023-03-236,857— $06,857SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2023-03-162023-03-236,820— $06,820SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2023-03-162023-03-2311,884— $011,884SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2023-03-062023-03-083,257— $03,257SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2023-03-062023-03-081,523— $016,328SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2022-09-202022-09-2210,500— $010,500SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2022-03-072022-03-085,077— $05,077SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2022-03-072022-03-096,820— $06,820SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2022-03-072022-03-082,953— $014,805SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2021-04-192022-03-0911,884— $011,884SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2021-04-192021-04-2111,884— $011,884SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2021-03-032021-03-055,518— $05,518SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2021-03-032021-03-052,726— $011,852SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2020-02-282020-02-283,685— $03,685SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2020-02-282020-02-282,075— $09,126SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2019-03-042019-03-043,213— $03,213SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2019-03-042019-03-041,633— $07,051SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2018-03-052018-03-074,820— $04,820SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2018-03-052018-03-073,418— $05,418SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2017-03-102017-03-1412,350— $012,350SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2017-03-102017-03-141,000— $02,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2016-02-292016-03-0210,500— $010,500SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2016-02-292016-03-021,000— $01,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2015-06-022015-06-049,746— $09,746SEC↗